Anebulo Pharmaceuticals Shares Dive After Board Votes to Exit Nasdaq
Anebulo Pharmaceuticals Inc. (NASDAQ: ANEB) saw its shares fall sharply after the company announced plans to voluntarily delist from the Nasdaq Capital Market and deregister its common stock with the SEC. The board said costs of maintaining public reporting status outweigh the benefits, and the company will file paperwork in mid-February 2026 to ma…